Global Visceral Pain Market Report 2024

Visceral Pain Global Market Report 2024 – By Drug Class (Calcium Channel Blockers, Nonsteroidal Anti-Inflammatory (NSAID), Other Drug Classes), By Indications (Interstitial Cystitis, Crohn’s, Irritable Bowel, Chronic Prostatitis, Other Indications), By End Users (Hospitals, Homecare, Specialty Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

Visceral Pain Global Market Report 2024

Starting Price : $5000.00 | Pages : 175 | Published : March 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs
Customise Your Report
Request For Proposal
Request For Regional Data

Need assistance or more information before the purchase?

Enquire Before Buying
Visceral Pain Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Visceral Pain Market Definition And Segments

Visceral pain refers to the pain that originates from the internal organs, such as the stomach, bladder, uterus, or rectum. Visceral pain can be caused by various factors, including inflammation, menstrual cramps, swelling and stretching of the organs, blockage, decreased blood flow, and tumors, especially when concentrated in the pelvis or abdomen. It is commonly associated with additional symptoms such as nausea, perspiration, or an accelerated heartbeat.

The main types of visceral pain drug class are calcium channel blockers, nonsteroidal anti-inflammatories (NSAID), and others. Calcium channel blockers (CCBs) refer to a class of medications that primarily affect the movement of calcium ions into the cells of the heart and blood vessels. The various indications include interstitial cystitis, Crohn’s, irritable bowel, chronic prostatitis, and others. These are used by various end-users such as hospitals, homecare, specialty clinics, and others.

The visceral pain market covered in this report is segmented –

1) By Drug Class: Calcium Channel Blockers, Nonsteroidal Anti-Inflammatory (NSAID), Other Drug Classes

2) By Indications: Interstitial Cystitis, Crohn’s, Irritable Bowel, Chronic Prostatitis, Other Indications

3) By End Users: Hospitals, Homecare, Specialty Clinics, Other End Users

The visceral pain treatment market size has grown strongly in recent years. It will grow from $12.87 billion in 2023 to $13.84 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to aging population, increased incidence of chronic diseases, advances in medical research, expansion of healthcare infrastructure, rising awareness and diagnosis rates.

The visceral pain treatment market size is expected to see strong growth in the next few years. It will grow to $17.70 billion in 2028 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to technological innovations in pain management, growing demand for non-invasive treatment options, emerging markets and untapped opportunities, personalized medicine approaches, integration of digital health solutions. Major trends in the forecast period include shift towards multimodal pain management, increasing emphasis on alternative therapies, rise of targeted therapies for specific pain types, growing role of telemedicine in pain management, integration of artificial intelligence in pain assessment.

Notable Surge In Buprenorphine Prescriptions Propels Visceral Pain Market Expansion

The rising demand for analgesics is expected to fuel the growth of the visceral pain market going forward. Analgesics refer to medications that alleviate pain by diminishing or blocking the perception of pain signals in the brain. Analgesics help manage visceral pain by targeting the nervous system and modulating pain signals originating from internal organs. For instance, in December 2023, according to the Centers for Disease Control and Prevention (CDC), a US-based, science-based, data-driven organization that protects public health in the United States, meticulously documented, a total number of dispensed Buprenorphine (an opioid analgesic) prescriptions saw a notable increase from 16,011,239 in 2020 to 16,105,318 in 2021, which represents a notable 0.59% increase when contrasted with the corresponding period in 2020. Therefore, the rising demand for analgesics is driving the growth of the visceral pain market.

Major companies operating in the visceral pain market are Walgreens Boots Alliance Inc., Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co.Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy's Laboratories Ltd., Endo International PLC, Grünenthal GmbH, Glenmark Pharmaceuticals Limited, Hisamitsu Pharmaceutical Co. Ltd., Chromocell Corporation, Addex Therapeutics Ltd.

Innovative NHE3 Inhibitor Advances Visceral Pain Treatment

Major companies operating in the visceral pain market are developing innovative products, such as NHE3 Inhibitor, to provide reliable services to customers. NHE3 inhibitors are a class of medicines that work by inhibiting the Sodium-Proton-Exchanger subtype 3 (NHE3) in the gut. For instance, in April 2022, Ardelyx, a US-based biopharmaceutical company, launched an NHE3 Inhibitor drug, IBSRELA. IBSRELA represents a pioneering treatment for adults with irritable bowel syndrome with constipation (IBS-C), and it works by inhibiting the Sodium-Hydrogen Exchanger 3 (NHE3) in the small intestine and colon. It has been shown to reduce abdominal pain by decreasing visceral hypersensitivity and intestinal permeability in animal studies.

Jazz Pharmaceuticals' Strategic Acquisition Of GW Pharmaceuticals

In February 2021, Jazz Pharmaceuticals, an Ireland-based pharmaceutical company, acquired GW Pharmaceuticals plc for $7.2 billion. With this acquisition, Jazz Pharmaceuticals is expected to gain access to GW's diversified portfolio of cannabinoid products, including Epidiolex, the first plant-derived cannabinoid medicine approved by the U.S. FDA. GW Pharmaceuticals plc is a US-based biopharmaceutical company that discovers, develops, and commercializes novel therapeutics for chronic visceral pain syndromes.

North America was the largest region in the visceral pain market in 2023. The regions covered in the visceral pain market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the visceral pain market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The visceral pain market consists of sales of opioids, anticonvulsants, gabapentin, and pregabalin. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The visceral pain market research report is one of a series of new reports from The Business Research Company that provides visceral pain market statistics, including visceral pain industry global market size, regional shares, competitors with a visceral pain market share, detailed visceral pain market segments, market trends, and opportunities, and any further data you may need to thrive in the visceral pain industry. This visceral pain market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Visceral Pain Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $13.84 billion
Revenue Forecast In 2033 $17.70 billion
Growth Rate CAGR of 6.3% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Drug Class: Calcium Channel Blockers, Nonsteroidal Anti-Inflammatory (NSAID), Other Drug Classes
2) By Indications: Interstitial Cystitis, Crohn’s, Irritable Bowel, Chronic Prostatitis, Other Indications
3) By End Users: Hospitals, Homecare, Specialty Clinics, Other End Users
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Walgreens Boots Alliance Inc.; Pfizer Inc.; Johnson & Johnson Services Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co.Inc.; AbbVie Inc.; Novartis AG; Sanofi SA; Bristol-Myers Squibb Company; AstraZeneca PLC; GlaxoSmithKline PLC; Takeda Pharmaceutical Company Limited; Eli Lilly and Company; Teva Pharmaceutical Industries Ltd.; Mylan N.V.; Bausch Health Companies Inc.; Sun Pharmaceutical Industries Ltd.; Perrigo Company PLC; Dr. Reddy's Laboratories Ltd.; Endo International PLC; Grünenthal GmbH; Glenmark Pharmaceuticals Limited; Hisamitsu Pharmaceutical Co. Ltd.; Chromocell Corporation; Addex Therapeutics Ltd.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Visceral Pain Market Characteristics

    3. Visceral Pain Market Trends And Strategies

    4. Visceral Pain Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Visceral Pain Market Size and Growth

    5.1. Global Visceral Pain Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Visceral Pain Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Visceral Pain Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Visceral Pain Market Segmentation

    6.1. Global Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Calcium Channel Blockers

    Nonsteroidal Anti-Inflammatory (NSAID)

    Other Drug Classes

    6.2. Global Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Interstitial Cystitis

    Crohn’s

    Irritable Bowel

    Chronic Prostatitis

    Other Indications

    6.3. Global Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospitals

    Homecare

    Specialty Clinics

    Other End Users

    7. Visceral Pain Market Regional And Country Analysis

    7.1. Global Visceral Pain Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Visceral Pain Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Visceral Pain Market

    8.1. Asia-Pacific Visceral Pain Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Visceral Pain Market

    9.1. China Visceral Pain Market Overview

    9.2. China Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Visceral Pain Market

    10.1. India Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Visceral Pain Market

    11.1. Japan Visceral Pain Market Overview

    11.2. Japan Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Visceral Pain Market

    12.1. Australia Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Visceral Pain Market

    13.1. Indonesia Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Visceral Pain Market

    14.1. South Korea Visceral Pain Market Overview

    14.2. South Korea Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Visceral Pain Market

    15.1. Western Europe Visceral Pain Market Overview

    15.2. Western Europe Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Visceral Pain Market

    16.1. UK Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Visceral Pain Market

    17.1. Germany Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Visceral Pain Market

    18.1. France Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.2. France Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.3. France Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Visceral Pain Market

    19.1. Italy Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.2. Italy Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.3. Italy Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Visceral Pain Market

    20.1. Spain Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.2. Spain Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.3. Spain Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Visceral Pain Market

    21.1. Eastern Europe Visceral Pain Market Overview

    21.2. Eastern Europe Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Visceral Pain Market

    22.1. Russia Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Visceral Pain Market

    23.1. North America Visceral Pain Market Overview

    23.2. North America Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Visceral Pain Market

    24.1. USA Visceral Pain Market Overview

    24.2. USA Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Visceral Pain Market

    25.1. Canada Visceral Pain Market Overview

    25.2. Canada Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Visceral Pain Market

    26.1. South America Visceral Pain Market Overview

    26.2. South America Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Visceral Pain Market

    27.1. Brazil Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Visceral Pain Market

    28.1. Middle East Visceral Pain Market Overview

    28.2. Middle East Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Visceral Pain Market

    29.1. Africa Visceral Pain Market Overview

    29.2. Africa Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Visceral Pain Market Competitive Landscape And Company Profiles

    30.1. Visceral Pain Market Competitive Landscape

    30.2. Visceral Pain Market Company Profiles

    30.2.1. Walgreens Boots Alliance Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Pfizer Inc.

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Johnson & Johnson Services Inc.

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. F. Hoffmann-La Roche Ltd.

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Merck & Co.Inc.

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Visceral Pain Market Other Major And Innovative Companies

    31.1. AbbVie Inc.

    31.2. Novartis AG

    31.3. Sanofi SA

    31.4. Bristol-Myers Squibb Company

    31.5. AstraZeneca PLC

    31.6. GlaxoSmithKline PLC

    31.7. Takeda Pharmaceutical Company Limited

    31.8. Eli Lilly and Company

    31.9. Teva Pharmaceutical Industries Ltd.

    31.10. Mylan N.V.

    31.11. Bausch Health Companies Inc.

    31.12. Sun Pharmaceutical Industries Ltd.

    31.13. Perrigo Company PLC

    31.14. Dr. Reddy's Laboratories Ltd.

    31.15. Endo International PLC

    32. Global Visceral Pain Market Competitive Benchmarking

    33. Global Visceral Pain Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Visceral Pain Market

    35. Visceral Pain Market Future Outlook and Potential Analysis

    35.1 Visceral Pain Market In 2028 - Countries Offering Most New Opportunities

    35.2 Visceral Pain Market In 2028 - Segments Offering Most New Opportunities

    35.3 Visceral Pain Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Visceral Pain Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Visceral Pain Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Walgreens Boots Alliance Inc. Financial Performance
  • Table 75: Pfizer Inc. Financial Performance
  • Table 76: Johnson & Johnson Services Inc. Financial Performance
  • Table 77: F. Hoffmann-La Roche Ltd. Financial Performance
  • Table 78: Merck & Co.Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Visceral Pain Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Visceral Pain Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Walgreens Boots Alliance Inc. Financial Performance
  • Figure 75: Pfizer Inc. Financial Performance
  • Figure 76: Johnson & Johnson Services Inc. Financial Performance
  • Figure 77: F. Hoffmann-La Roche Ltd. Financial Performance
  • Figure 78: Merck & Co.Inc. Financial Performance
The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth
Read More
Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis
Read More
How Will The Nuclear Medicine Market Grow In 2022?
Read More
What Is The Pediatric Imaging Market Overview In 2022?
Read More
Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company
Read More
Ostomy Devices Global Market Report 2024 – By Product (Bags, Accessories), By System Type (One-Piece System, Two-Piece System), By Surgery Type (Colostomy, Urostomy, Ileostomy), By End Users (Ambulatory Surgical Centers, Hospitals, Home Care, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Artificial Turf Global Market Report 2024 – By Material Type (Polyethylene, Polypropylene, Nylon, Other Materials), By Installation (Flooring, Wall Cladding), By Application (Residential, Commercial, Sports) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Insurance Analytics Global Market Report 2024 – By Component (Solution, Service), By Deployment Model (On premises, Cloud), By Enterprise Size (Large Enterprises, Small And Medium Enterprises (SMEs)), By Application (Claims Management, Risk Management, Customer Management And Personalization, Process Optimization, Other Applications), By End User (Insurance Companies, Government Agencies, Third Party Administrators, Brokers And Consultancies) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Field Programmable Gate Array Global Market Report 2024 – By Technology( EEPROM, Antifuse, SRAM, Flash, Other Technologies ), By Configuration( High-end FPGA, Mid-end FPGA, Low-end FPGA), By Application( Data processing, Consumer Electronics, Industrial, Military and Aerospace, Automotive, Telecom, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Shale Gas Processing Equipment Global Market Report 2024 – By Component (Compressors and Pumps, Electrical Machinery, Heat Exchangers, Internal Combustion Engines, Measuring and Controlling Devices, Others Components ), By Process (Distillation, Pyrolysis, Reheating, Cracking, Chemical Treatment), By Application (Pipeline, Natural Gas Processing Plants, LNG or LPG Facilities, Crude by Rail, Other Midstream Applications) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Industrial Fasteners Global Market Report 2024 – By Type (Externally Threaded, Internally Threaded, Non-Threaded, Aerospace Grade), By Raw Material (Metal, Plastic), By Application (Automotive, Aerospace, Construction, Industrial Machinery, Plumbing Products, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Headset Global Market Report 2024 – By Type (In-Ear, Over Ear), By Price Band (Below USD 50, USD 51-150, USD 151-350, Over USD 351), By Connectivity (Wired, Wireless), By Application (Smartphone, Personal Computer (PC), Wearable, Other Applications ) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Specialty Consumer Products Global Market Report 2024 – By Price ($50 - $100, $100 - $200, Above $200 ), By Distribution Channel (Specialty Stores, Online Stores ), By End-User (Male, Female, Unisex) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the visceral pain market?

Visceral pain refers to the pain that originates from the internal organs, such as the stomach, bladder, uterus, or rectum. Visceral pain can be caused by various factors, including inflammation, menstrual cramps, swelling and stretching of the organs, blockage, decreased blood flow, and tumors, especially when concentrated in the pelvis or abdomen. It is commonly associated with additional symptoms such as nausea, perspiration, or an accelerated heartbeat. For further insights on the visceral pain market, request a sample here

How will the visceral pain market drivers and restraints affect the visceral pain market dynamics? What forces will shape the visceral pain industry going forward?

The visceral pain market major growth driver - Notable Surge In Buprenorphine Prescriptions Propels Visceral Pain Market Expansion. For further insights on the visceral pain market, request a sample here

What is the forecast market size or the forecast market value of the visceral pain market?

The visceral pain treatment market size has grown strongly in recent years. It will grow from $12.87 billion in 2023 to $13.84 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to aging population, increased incidence of chronic diseases, advances in medical research, expansion of healthcare infrastructure, rising awareness and diagnosis rates. The visceral pain treatment market size is expected to see strong growth in the next few years. It will grow to $17.70 billion in 2028 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to technological innovations in pain management, growing demand for non-invasive treatment options, emerging markets and untapped opportunities, personalized medicine approaches, integration of digital health solutions. Major trends in the forecast period include shift towards multimodal pain management, increasing emphasis on alternative therapies, rise of targeted therapies for specific pain types, growing role of telemedicine in pain management, integration of artificial intelligence in pain assessment. For further insights on the visceral pain market, request a sample here

How is the visceral pain market segmented?

The visceral pain market is segmented
1) By Drug Class: Calcium Channel Blockers, Nonsteroidal Anti-Inflammatory (NSAID), Other Drug Classes
2) By Indications: Interstitial Cystitis, Crohn’s, Irritable Bowel, Chronic Prostatitis, Other Indications
3) By End Users: Hospitals, Homecare, Specialty Clinics, Other End UsersFor further insights on the visceral pain market, request a sample here

Which region has the largest share of the visceral pain market? What are the other regions covered in the report?

North America was the largest region in the visceral pain market in 2023. The regions covered in the visceral pain market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the visceral pain market, request a sample here.

Who are the major players in the visceral pain market?

Major companies operating in the visceral pain market report are Walgreens Boots Alliance Inc., Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co.Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy's Laboratories Ltd., Endo International PLC, Grünenthal GmbH, Glenmark Pharmaceuticals Limited, Hisamitsu Pharmaceutical Co. Ltd., Chromocell Corporation, Addex Therapeutics Ltd., , , , , , For further insights on the visceral pain market, request a sample here.

What are the key trends in the visceral pain market?

Major trend in the visceral pain market - Innovative NHE3 Inhibitor Advances Visceral Pain Treatment. For further insights on the visceral pain market, request a sample here.

What are the major opportunities in the visceral pain market? What are the strategies for the visceral pain market?

For detailed insights on the major opportunities and strategies in the visceral pain market, request a sample here.

How does the visceral pain market relate to the overall economy and other similar markets?

For detailed insights on visceral pain market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the visceral pain industry?

For detailed insights on the mergers and acquisitions in the visceral pain industry, request a sample here.

What are the key dynamics influencing the visceral pain market growth? SWOT analysis of the visceral pain market.

For detailed insights on the key dynamics influencing the visceral pain market growth and SWOT analysis of the visceral pain industry, request a sample here.